MT2 also has appetite-suppressing properties, offering additional benefits beyond its tanning effects.
$30.00
Out of stock
THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE. ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
References to human benefits are based on theoretical extrapolation from laboratory findings and should not be construed as medical claims or therapeutic recommendations. Research should be conducted only by licensed researchers in appropriate laboratory settings.
These products are not intended to be used as foods, drugs or cosmetics, any sort of bodily introduction of the products into humans or animals is strictly prohibited. They must also not be misbranded misused, or mislabeled, or used for anything other than research and scientific investigation.
All the products you see on the website are being sold in a lyophilized powder state (freeze-dried), in a sealed sterile vial; and should be reconstituted.
The product’s label clearly states the amount of product a vial contains; some products are offered in different variations.
The products we are selling come in a sealed vial but require additional lab equipment for proper testing. This equipment includes bacteriostatic water (for reconstitution), syringes and needles (to draw the product from the vial/apply bacteriostatic water), alcohol disinfection pads etc.
Though we make sure packaging, label, seals and writing does not differ from the product photos you see on our website, there is a chance for a minimal deviation.
Melanotan II (MT2) represents a synthetic cyclic heptapeptide analog of α-melanocyte-stimulating hormone (α-MSH), developed through structure-activity relationship studies. This peptide demonstrates high binding affinity for melanocortin receptors, particularly MC1R and MC4R, exhibiting multifaceted physiological effects in research models. Initial investigations emerged from University of Arizona studies exploring melanocortin receptor activation mechanisms.
MT2 consists of a modified cyclic structure with the sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2. The cyclic conformation, achieved through lactam bridge formation between aspartic acid and lysine residues, confers enhanced stability and receptor binding characteristics compared to linear analogs. This structural modification results in:
Studies demonstrate MT2’s interaction with multiple melanocortin receptor subtypes, with particular emphasis on:
Research models indicate significant vascular effects through:
Investigation of cellular mechanisms reveals:
Laboratory research has documented several areas of interest:
Current research protocols typically employ:
All research findings discussed herein derive from controlled laboratory studies and in vitro research models. This information is intended strictly for research and educational purposes. The peptide requires specific laboratory conditions and handling protocols for investigational use.
Research applications typically utilize:
Renogenix focuses on the synthesis of highly purified peptides, proteins, and amino acid derivatives for scientific research and development.
Renogenix focuses on the synthesis of highly purified peptides, proteins, and amino acid derivatives for scientific research and development.